Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

The corporate and investor mindset: What types of anti-cancer drugs and clinical research proposals will be prioritised in the near term?

Regulatory and market access challenges in oncology drug development

Date

05 Mar 2025

Session

The corporate and investor mindset: What types of anti-cancer drugs and clinical research proposals will be prioritised in the near term?

Topics

Targeted Therapy

Tumour Site

Presenters

Shaily Arora

Authors

S. Arora

Author affiliations

  • AstraZeneca Pharmaceuticals LP, 20878 - Gaithersburg/US

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.